López Lacort, M., Múñoz Quiles, C., Mira Iglesias, A., López Labrador, F. X., Mengual Chuliá, B., Fernández García, C., . . . Orrico Sánchez, A. (2024). Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.
Citación estilo ChicagoLópez Lacort, Mónica, et al. Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission for Respiratory Syncytial Virus Lower Respiratory Tract Infections in Infants, Spain, October 2023 to January 2024. 2024.
Cita MLALópez Lacort, Mónica, et al. Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission for Respiratory Syncytial Virus Lower Respiratory Tract Infections in Infants, Spain, October 2023 to January 2024. 2024.